LIBERATE Study
STUDY BASICS
Are you between the ages of 40 and 75 and have emphysema? If so, you may be eligible to participate in a study to evaluate the lung function and safety of the Pulmonx Endobronchial Valve (EBV) for treating people who have severe emphysema. Eligible participants are non-smokers or ex-smokers of at least 4 months. Must undergo a bronchoscopy procedure to qualify for study. Compensation provided.
IRB: 20122099
- LIBERATE StudyMEET THE RESEARCHER

Frank C. Sciurba
Frank C. Sciurba, MD is a Professor of Medicine at the University of Pittsburgh School of Medicine and is the medical director of the Pulmonary Physiology Laboratory in the Division of Pulmonary, Allergy and Critical Care Medicine. Dr. Sciurba’s research has been inspired by real clinical problems facing his patients. He has co-authored over 200 manuscripts and has had National Institutes of Health funding for 20 years including a Specialized Clinical Center of Research Excellence in COPD.